Abstract
Attention-deficit/ hyperactivity disorder (ADHD) is the most common neurodevelopment disorder in children, and many genetic markers have been linked to the behavioral phenotypes of this highly heritable disease. The neuroimaging correlates are similarly complex, with multiple combinations of structural and functional alterations associated with the disease presentations of hyperactivity and inattentiveness. Thus far, neuroimaging studies have provided mixed results in ADHD patients, particularly with respect to the laterality of findings. It is possible that hemispheric asymmetry differences may help reconcile the variability of these findings. We recently reported that inter-hemispheric asymmetry differences were more sensitive descriptors for identifying differences between ADHD and typically developing (TD) brains (n=849) across volumetric, morphometric, and white matter neuroimaging metrics. Here, we examined the replicability of these findings across a new data set (n=202) of TD and ADHD subjects at the time of diagnosis (medication naive) and after a six week course of either stimulant drugs, non-stimulant medications, or combination therapy. Our findings replicated our earlier work across a number of volumetric and white matter measures confirming that asymmetry is more robust at detecting differences between TD and ADHD brains. However, the effects of medication failed to produce significant alterations across either lateralized or symmetry measures. We suggest that the delay in brain volume maturation observed in ADHD youths may be hemisphere dependent. Future work may investigate the extent to which these inter-hemispheric asymmetry differences are causal or compensatory in nature.
Keywords: Attention-deficit/hyperactivity disorder, ADHD, whiter matter, brain asymmetry, MRI, DTI, stimulants
1. INTRODUCTION
Human brains are not symmetric. Normal variation and functional specialization produce asymmetries of structure, function, and behavior that evolve throughout life, and are thought to originate from developmental, hereditary, experiential and pathological factors (Toga and Thompson, 2003). However, certain pathologies can also modulate, exacerbate, or arise from brain asymmetries (Thompson et al., 1998), (Crow, 1997).
Attention itself induces functional asymmetries in healthy individuals. For example, PET and EEG studies suggest that attention directed to global aspects of visual processing are more right lateralized, but local processing is more left hemisphere dominant (Fink et al., 1996), (Yamaguchi et al., 2000). A number of studies have investigated the link between structural brain asymmetries and attention-deficit/hyperactivity disorder (ADHD) (Rubia et al., 2000), (Hale et al., 2015), (Shaw et al., 2009a), and its characteristic behavioral systems such as impulsivity (Gordon, 2016). Early lesion studies suggested a role for unilateral right hemisphere dysfunction in ADHD (Heilman and Van Den Abell, 1980), (Stefanatos and Wasserstein, 2001). However, the patterns of brain asymmetry and its relationship to one’s ability to sustain attention appears to be more complex. For example, decreased asymmetry in ADHD subjects was observed, using homologous points on the cortex for comparison (Shaw et al., 2009a). However this study population consisted mostly of subjects with a history of psychostimulant medication (Shaw et al., 2009a), and it is possible that atypical structural asymmetry may be resolved or altered over the course of pharamacotherapy.
Recently, we examined altered patterns of inter-hemispheric asymmetry in a large cohort of ADHD youths and typically developing (TD) controls. Patterns of altered asymmetry differences were found in white matter mean diffusivity (MD) in cingulum, inferior and superior longitudinal fasciculus, and cortico-spinal tracts (p<0.001) with the effect of stimulant treatment tending to reduce these patterns of asymmetry differences. Gray matter volumes were more asymmetric in medication free ADHD individuals compared to TD in twelve cortical regions and two non-cortical volumes studied (p<0.05). Overall, asymmetry group differences were more significant than lateralized comparisons between ADHD and TD subjects across morphometric, volumetric, and DTI comparisons. In the present work, we sought to test the replicability of these findings using comparable methods on a new data neuroimaging data set.
2. METHODS
2.1. Subjects and Study Design
Parents and participants provided written informed permission and assent, respectively, prior to commencing the study which was approved by the UCLA Institutional Review Board. The study was an 8 week double-blind, randomized control trial the following treatment conditions: placebo only, d-methylphenidate (MPH) extended release (5–20 mg/day) + placebo, guanfacine (GUAN) + placebo, and combination (GUAN+MPH). Subjects aged 7 to 14, consisted of children who met DSM-IV diagnostic criteria for ADHD and age-matched TD youths (n = 202). The subjects were recruited as part of the UCLA Translational Research to Enhance Cognitive Control Center (TRECC). An ADHD diagnosis was determined via a semi-structured diagnostic interview (Kiddie-Schedule for Affective Disorders and Schizophrenia–Present and Lifetime version (K-SADS-PL; Kaufman et al., 1997) and a Clinical Global Impression-Severity (CGI-S) score ≥ 4. Exclusion criteria included: autistic disorder, chronic tic disorder, psychosis, bipolar disorder, structural heart defects, blood pressure >95th or below <5th percentile for age and body mass index, or a medical condition which precluded the use of stimulants or alpha agonists. For additional details, see McCracken et al. 2016. Neuropsychological data was acquired at the baseline visit which included obtaining scores for the Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Rating (SWAN). Subjects also completed stop signal reaction time (SSRT), short working memory (SWM) and go-no-go behavioral tasks.
2.1. Neuroimaging & Preprocessing
All neuroimaging protocols took place at baseline shortly after diagnosis (Time 1), and after an eight weeks course of placebo, MPH+placebo, GUAN+placebo, or combination MPH/GUAN (Time 2). Data were collected on a 3 Tesla Siemens Allegra Scanner at the UCLA Ronald Reagan Medical Center. High resolution T1 weighted MPRAGE anatomical MRI scans were processed with FreeSurfer’s recon-all processing pipeline for whole brain segmentation and automated parcellation (Fischl and Dale, 2000). This generates segmentations for white matter, gray matter, and subcortical volumes. A mesh model of the cortical surface was then divided into 34 cortical brain regions, and for 14 subcortical and non-cortical regions per hemisphere. Total volume (mm3) for each region was used for group comparisons.
The diffusion tensor imaging (DTI) protocol consisted of axial multislice single-shot echo-planar imaging (EPI) sequence with the following parameters: repetition time [TR]/echo time [TE] = 7300/95 msec, flip angle = 90°, field of view (FOV) = 240mm2, slice thickness = 2.5mm, no slice gap, number of slices = 55, k-space matrix = 96×96, image matrix = 192×192, voxel size=2.5mm3, with 30 diffusion gradient directions taken from Jones et al. (2002), b=800s/mm2, and 5 non-diffusion-weighted volumes with b=0. All imaging data were analyzed using the FMRIB Software Library (FSL). Preprocessing included eddy current distortion correction and brain extraction. Diffusion tensors were estimated at each voxel using dtifit to calculate fractional anisotropy (FA) maps, where were registered to each subjects T1-weighted structural scan, followed by group registration the the Johns Hopkins diffusion tensor imaging (DTI) white matter (WM) atlas http://cmrm.med.jhmi.edu/; Wakana et al., 2004).
2.2. Statistical Analysis
All statistical analyses were consistent with our previously described methods (Douglas et al. 2018). In brief, for each MRI volumetric and DTI measure, we first computed within-hemisphere statistics for group comparisons (e.g., TD right hemisphere caudate volume versus ADHD right hemisphere caudate volume). To assess brain inter-hemispheric symmetry differences between ADHD and TD populations for each structural parameter, we calculated the asymmetry index (AI) as the difference between the left and right hemispheres divided by the mean. We assessed the absolute value of AI for each subject and imaging measure. Crucially, this method allows individual brains to serve as their own anatomic control, diminishing the influence of other variables such as gender and maturation between scanning sessions.
We used a general linear mixed effects model to study the relationship between within-hemisphere and AI differences in ADHD (Bates et al., 2012). Fixed effects included: site of data collection, age, sex, diagnosis, and their interactions, to account for known differences in maturation rates in the ADHD population (Larisch et al., 2006),(Castellanos and Proal, 2009). P-values were obtained by likelihood ratio tests of the full model against the null-model that disregarded the influence of diagnosis. All code for this analysis was implemented in R (R Core Team, 2012), using the linear mixed-effects lme model tool (Bates et al., 2012). All reported p-values were adjusted to correct for multiple comparisons (Benjamini and Hochberg, 1995) within our code. Participant ID was included as a random effect within the model to account for multiple comparisons.
3. RESULTS
3.1. Study Cohort
For Time 1, the mean age for ADHD and TD subjects were 9.8 ± 2.0 and 10.5 ± 2.2, respectively (mean ± standard deviation; see Table 1). Approximately 27% of ADHD and 61% of TD subjects were females. Due to attrition of subjects over the course of the experiment, the demographics were slightly altered in the subset who returned for the followup imaging session. At Time 2, the mean age for subjects in the TD group was 11 ± 2.4 (21% female) and the mean age for subjects in the ADHD group was 9.8 ± 2.1 (29% female). SWAN scores were only assessed at baseline. Mean SWAN scores were 62.9 ± 22.7 and 118.2 ± 27.8 for ADHD and TD, respectively. A summary of the results from the behavioral task is shown in Table 1.
Table 1:
Summary of behavioral results for ADHD and TD groups at baseline and after treatment.
| SWM Accuracy | SWM Response Rate | Stop-Signal SSRT | Stop Signal % Go Trials Correct | Stop Signal % Inhibit Trials Correct | |
|---|---|---|---|---|---|
| Baseline | |||||
| ADHD | 68.6 ± 11.5 | 88.4 ± 17.1 | 308.7 ± 140.7 | 90 ± 11.2 | 44.4 ± 16.3 |
| TD | 73.6 ± 11.4 | 92.7 ± 13.2 | 264.3 ± 116.3 | 95.8 ± 6.6 | 49.3 ± 13.7 |
| After Treatment | |||||
| Methylphenidate | 67.6 ± 13.0 | 92.4 ± 10.0 | 243.6 ± 113 | 93.1 ± 11.8 | 47 ± 13.7 |
| Guanfacine | 67.1 ± 13.8 | 86.5 ± 19.4 | 204.8 ± 166.5 | 88 ± 19.5 | 50.3 ± 15.2 |
| Combined | 70.1 ± 9.5 | 93.3 ± 9.5 | 204.7 ± 135.2 | 89.1 ± 19.2 | 53.3 ± 13.7 |
| All ADHD | 68.3 ± 12.7 | 90.8 ± 13.8 | 219.5 ± 139 | 90.2 ± 17 | 50 ± 14.4 |
| TD | 78.1 ± 9.0 | 90.2 ± 19.3 | 244.4 ± 120.2 | 92.1 ± 18 | 48.4 ± 16 |
3.2. Volumetric Neuroimaging Findings
After adjustment for age, sex, diagnosis, and their interactions, we observed statistically significant cortical gray matter volume differences for group comparisons between TD and ADHD-Free (medication naïve) subjects in lateralized comparisons (Table 2) including: rostral middle frontal, inferior parietal, inferior temporal (p<0.05), and superior frontal (p<0.01) in the right hemisphere, and lateral orbitofrontal, precentral (p<0.05), rostral middle frontal, superior parietal (p<0.01), and the superior frontal (p<0.001) in the left hemisphere. For Asymmetry Index (AI), the following brain regions were significantly different for group comparisons in the entorhinal, fusiform (p<0.001), and the rostral anterior cingulate (p<0.05). In contrast, absolute asymmetry index was significantly different in nine cortical gray matter volumes with focus in the frontal regions. In all absolute AI comparisons, the mean absolute magnitude of AI was greater in the ADHD-Free group compared to TD subjects (see Table 2).
Table 2:
P-values are shown comparing Typically Developing (TD) and ADHD-Free participants in Time 1 for Cortical Gray Matter volumetric results. These comparisons were done for the following: TD versus ADHD-Free Left Hemisphere, TD versus ADHD-Free Right Hemisphere, TD versus ADHD-Free Asymmetry Index (AI), and TD versus ADHD-Free absolute Asymmetry Index (Abs(AI)). The p-values shown were corrected for multiple comparisons, with significant comparisons in bold. A + sign indicates the measure to be larger in the ADHD group. In all lateralized (left and right) bold cases, the ADHD group had smaller (estimates) volumes.
| Cortical Gray Matter Volumetric Results Typically Developing vs. ADHD-Free | |||||
|---|---|---|---|---|---|
|
| |||||
| Region | Gray Matter Volume | Right | Left | AI | Abs (AI) |
| Cingulate | Caudal Middle Frontal | 0.612 | 0.598 | 0.397 | 0.049 + |
| Isthmus cingulate | 0.751 | 0.438 | 0.224 | 0.234 | |
| Posterior Cingulate | 0.961 | 0.969 | 0.662 | 0.309 | |
| Rostral Anterior Cingulate | 0.957 | 0.471 | 0.0309 | 0.206 | |
| Frontal | Lateral Orbito-frontal | 0.119 | 0.048 | 0.290 | 0.132 |
| Medial orbitofrontal | 0.393 | 0.485 | 0.522 | 0.003 + | |
| Paracentral | 0.648 | 0.749 | 0.338 | 0.202 | |
| Pars Opercularis | 0.871 | 0.483 | 0.065 | 0.255 | |
| Pars orbitalis | 0.784 | 0.635 | 0.286 | 0.014 + | |
| Pars Triangularis | 0.948 | 0.603 | 0.088 | 0.060 | |
| Rostral Middle Frontal | 0.036 | 0.005 | 0.161 | 0.023 + | |
| Superior Frontal | 0.003 | 0.000 | 0.109 | 0.185 | |
| Frontal Pole | 0.738 | 0.897 | 0.053 | 0.012 + | |
| Occipital | Cuneus | 0.601 | 0.915 | 0.213 | 0.068 |
| Lateral Occipital | 0.794 | 0.617 | 0.058 | 0.616 | |
| Lingual | 0.501 | 0.810 | 0.246 | 0.186 | |
| Pericalcarine | 0.437 | 0.588 | 0.419 | 0.094 | |
| Parietal | Inferior Parietal | 0.023 | 0.153 | 0.362 | 0.149 |
| Postcentral | 0.812 | 0.619 | 0.206 | 0.030 + | |
| Precentral | 0.181 | 0.011 | 0.102 | 0.115 | |
| Precuneus | 0.103 | 0.179 | 0.329 | 0.139 | |
| Superior Parietal | 0.102 | 0.003 | 0.095 | 0.051 | |
| Supramarginal | 0.860 | 0.520 | 0.120 | 0.041 + | |
| Temporal | Entorhinal | 0.601 | 0.758 | 0.006 | 0.235 |
| Fusiform | 0.644 | 0.164 | 0.006 | 0.440 | |
| Inferior temporal | 0.022 | 0.054 | 0.626 | 0.201 | |
| Middle Temporal | 0.159 | 0.206 | 0.278 | 0.072 | |
| Superior Temporal | 0.232 | 0.378 | 0.434 | 0.007 + | |
| Temporal Pole | 0.861 | 0.973 | 0.498 | 0.016 + | |
| Transverse Temporal | 0.618 | 0.986 | 0.057 | 0.367 | |
| Parahippocampal | 0.987 | 0.873 | 0.190 | 0.696 | |
| Insular Cortex | Insula | 0.774 | 0.599 | 0.254 | 0.159 |
In a supplementary analysis, we examined presentation type among the ADHD-Free (Time 1) subjects. For AI, statistically significant regions included the entorhinal, fusiform, lateral occipital, parahippocampal and pars opercularis (p<0.05) in the inattentive type, and entorhinal and fusiform (p<0.05) in the combined type. There was an increase in absolute AI for nine regions in the inattentive type with focus in the frontal and temporal regions (pars orbitalis (p<0.001), medial orbitofrontal, rostral middle frontal (p<0.01), pericalcarine, superior parietal, supramarginal, middle temporal, superior temporal, and temporal pole (p<0.05)) and six regions in the combined type (caudal middle frontal, medial orbitofrontal, frontal pole, cuneus, superior temporal, and temporal pole (p<0.05)).
Additionally, we examined results for cortical gray matter volume comparisons between ADHD-Free (Time 1) versus ADHD-Rx (Time 2). The only significant differences were in absolute asymmetry index (AI) across the following regions (Table 3): medial orbitofrontal, pars orbitalis, rostral middle frontal, lateral occipital, lingual, pericalcarine, precentral, superior parietal, middle temporal, superior temporal, parahippocampal (p < 0.05), and supramarginal (p < 0.01). All regions had a decrease in absolute AI after treatment, indicating that medication overall tends to decrease asymmetry.
Table 3.
P-values are shown comparing ADHD participants before treatment and after treatment for Cortical Gray Matter volumetric results. These comparisons were done for the following: ADHD-Free versus ADHD-Rx Treatment Left Hemisphere, ADHD-Free versus ADHD-Rx Treatment Right Hemisphere, ADHD-Free versus ADHD-Rx Treatment Asymmetry Index (AI), and ADHD-Free versus ADHD-Rx Treatment Absolute Asymmetry Index (Abs(AI)). The p-values shown were corrected for multiple comparisons, with significant comparisons in bold. All regions displayed a decrease in Absolute AI for ADHD-Rx.
| Before versus After Treatment: Cortical Gray Matter Volumetric Results for ADHD-Free vs. ADHD-Rx | |||||
|---|---|---|---|---|---|
|
| |||||
| Region | Gray Matter Volume | Right | Left | AI | Abs (AI) |
| Cingulate | Caudal Middle Frontal | 0.582 | 0.714 | 0.622 | 0.226 |
| Isthmus cingulate | 0.559 | 0.597 | 0.837 | 0.083 | |
| Posterior Cingulate | 0.861 | 0.884 | 0.763 | 0.081 | |
| Rostral Anterior Cingulate | 0.733 | 0.948 | 0.143 | 0.213 | |
| Frontal | Lateral Orbito-frontal | 0.830 | 0.499 | 0.454 | 0.066 |
| Medial orbitofrontal | 0.655 | 0.918 | 0.313 | 0.018 | |
| Paracentral | 0.235 | 0.376 | 0.412 | 0.069 | |
| Pars Opercularis | 0.765 | 0.820 | 0.303 | 0.332 | |
| Pars orbitalis | 0.993 | 0.983 | 0.930 | 0.040 | |
| Pars Triangularis | 0.968 | 0.911 | 0.757 | 0.186 | |
| Rostral Middle Frontal | 0.725 | 0.629 | 0.563 | 0.032 | |
| Superior Frontal | 0.825 | 0.983 | 0.449 | 0.168 | |
| Frontal Pole | 0.602 | 0.653 | 0.949 | 0.744 | |
| Occipital | Cuneus | 0.354 | 0.534 | 0.463 | 0.092 |
| Lateral Occipital | 0.993 | 0.855 | 0.646 | 0.034 | |
| Lingual | 0.278 | 0.590 | 0.272 | 0.015 | |
| Pericalcarine | 0.347 | 0.418 | 0.816 | 0.037 | |
| Parietal | Inferior Parietal | 0.835 | 0.903 | 0.698 | 0.177 |
| Postcentral | 0.926 | 0.934 | 0.644 | 0.069 | |
| Precentral | 0.507 | 0.918 | 0.349 | 0.037 | |
| Precuneus | 0.829 | 0.908 | 0.758 | 0.091 | |
| Superior Parietal | 0.614 | 0.494 | 0.609 | 0.046 | |
| Supramarginal | 0.717 | 0.670 | 0.957 | 0.007 | |
| Temporal | Entorhinal | 0.645 | 0.798 | 0.780 | 0.126 |
| Fusiform | 0.580 | 0.741 | 0.472 | 0.124 | |
| Inferior temporal | 0.361 | 0.673 | 0.497 | 0.068 | |
| Middle Temporal | 0.621 | 0.625 | 0.130 | 0.041 | |
| Superior Temporal | 0.876 | 0.196 | 0.241 | 0.011 | |
| Temporal Pole | 0.786 | 0.951 | 0.341 | 0.257 | |
| Transverse Temporal | 0.600 | 0.802 | 0.273 | 0.273 | |
| Parahippocampal | 0.737 | 0.756 | 0.767 | 0.025 | |
| Insular Cortex | Insula | 0.909 | 0.844 | 0.717 | 0.162 |
We performed the same comparisons with subcortical regions and found fewer statistically significant results for lateralized and asymmetry measures between TD and ADHD-Free (Time 1). For the right hemisphere, the cerebellum was lower in volume (p<0.01, Table 6) for ADHD-Free subjects compared to TD subjects, see Table 4.
Table 4.
P-values are shown comparing Typically Developing (TD) and ADHD-Free participants in Time 1 for Subcortical volumetric results. These comparisons were done for the following: TD versus ADHD-Free Left Hemisphere, TD versus ADHD-Free Right Hemisphere, TD versus ADHD-Free Asymmetry Index (AI), and TD versus ADHD-Free absolute Asymmetry Index (Abs(AI)). The p-values shown were corrected for multiple comparisons, with significant comparisons in bold. In the bold case (Right hemisphere), the ADHD group had smaller volume in the cerebellum.
| P-values for Subcortical Volumes Typically Developing vs. ADHD-Free | ||||
|---|---|---|---|---|
|
| ||||
| Subcortical Region | Right | Left | AI | Abs (AI) |
| Amygdala | 0.981 | 0.958 | 0.963 | 0.893 |
| Caudate | 0.974 | 0.993 | 0.545 | 0.801 |
| Cerebellum-Cortex | 0.0088 | 0.058 | 0.752 | 0.960 |
| Choroid plexus | 0.959 | 0.945 | 0.594 | 0.691 |
| Hippocampus | 0.810 | 0.822 | 0.922 | 0.712 |
| Inferior Lateral Ventricle | 0.806 | 0.908 | 0.073 | 0.075 |
| Lateral Ventricle | 0.472 | 0.449 | 0.909 | 0.613 |
| Pallidum | 0.978 | 0.968 | 0.212 | 0.442 |
| Putamen | 0.870 | 0.791 | 0.224 | 0.350 |
| Thalamus | 0.805 | 0.748 | 0.925 | 0.946 |
| Ventral DC | 0.912 | 0.961 | 0.569 | 0.487 |
| Vessel | 0.964 | 0.938 | 0.348 | 0.087 |
3.2. White Matter Differences in the ADHD Brain
After adjustment for age and sex, significant differences were found for TD and ADHD-Free in the left hemisphere and all AI measures. Left hemisphere differences were significant in the superior fronto-occipital fasciculus for radial (perpendicular) diffusivity. Two tracts were found to be significant for AI, whereas three tracts were found to be significant in absolute AI. Fractional anisotropy (FA) differences were found in the cingulum. Mean diffusivity asymmetry differences were found in the uncinate fasciculus and sagittal stratum. Symmetry differences in radial (perpendicular) diffusivity were found for the superior fronto-occipital fasciculus. The corticospinal tract was significantly different across all AI and DTI measures (Figure 1).
Figure 1.

Illustrative figure of white matter tracts which were significantly different between the ADHD-Free and TD group. Sagittal and axial views are shown for the tracts: (a) uncinate fasciculus, (b) cingulum, (c) corticospinal tract, (d) sagittal stratum (includes inferior fronto-occipital fasciculus and inferior longitudinal fasciculus; Mori et al. 2008), and (e) superior fronto-occipital fasciculus. All images created were created using DSI studio data for visualization purposes.
4. DISCUSSION
Attention-deficit/hyperactivity disorder (ADHD) is a child-onset neurodevelopmental condition characterized by inattentiveness and/or hyperactivity-impulsivity. Meta-analyses report a 5.29% worldwide prevalence of ADHD for youths under the age of 18 (Polancyzk, et al., 2007), and these symptoms persist in about two-thirds of adults (Barkley et al., 2002, Faraone et al., 2006). There is a tremendous need to identify quantitative neuroimaging biomarkers of ADHD, which can inform intervention studies and therapies targeted to baseline phenotypes. Laterality (right versus left hemisphere) is often used as a metric for examining structural and functional MRI alterations of anatomy and physiology, but recently, these metrics have been called into question due to mixed results (i.e., increase and decrease) in laterality as shown in structural and functional brain studies (Emond et al., 2009; Nakao et al., 2011; Ellison-Wright et al., 2008; Paclt et al., 2016; Douglas et al., 2018; Hart et al., 2012).
Functional and structural brain asymmetries are a part of normal development. However, differences in these normal asymmetry patterns may also be pathologic. The symptoms of ADHD have long been associated with right hemisphere abnormalities as shown in behavioral and neuroimaging studies (Stefanatos & Wasserstein 2011; Heilman & Van Den Abell, 1980; Carter et al., 1995; Vance et al., 2007; Monden et al., 2015; Doi & Shinohara, 2017). However, more subtle patterns of atypical interhemispheric and lateralization have been revealed (Hale et al., 2009; Silk et al., 2016; Hasler et al., 2017; Segal et al., 2017). Overall, our work demonstrates that these asymmetries may be more useful for identifying differences in the ADHD brain. We suggest that future studies may examine the functional role of these asymmetry differences. Determining the extent to which these asymmetries evolve over development may be crucial, given considerable evidence that ADHD is associated with a delay in brain volume maturation (e.g., Hoogman et al. 2017). It is possible that this delay may be hemisphere specific. Furthermore, it is possible that multiple combinations of structural and functional brain abnormalities produce similar phenotypic presentations. Therefore, the delay in maturation may be variably lateralized within the ADHD population, yet result in similar issues with integrating sensory information across cortices. Further work may also reveal the if there is a correspondence between the persistence of altered AI and symptoms of ADHD carrying forward into adulthood. Given the complexity of genetic loci which are linked to hyperactivity and inattentiveness (McGough 2012), it may be difficult to determine whether these altered AI patterns play a causal or compensatory role in generating the ADHD behavioral manifestations.
REFERENCES
- [1].Anderson A, Douglas PK, Kerr WT, Haynes VS, Yuille AL, Xie J, Wu YN, Brown JA, Cohen MS, 2014. Non-negative matrix factorization of multimodal MRI, fMRI and phenotypic data reveals differential changes in default mode subnetworks in ADHD. NeuroImage 102 Pt 1, 207–219. doi: 10.1016/j.neuroimage.2013.12.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Bates D, Machler M, Bolker B, Walker S, 2012. Fitting Linear Mixed-Effects Models using lme4. J. Stat. Softw. [Google Scholar]
- [3].Benjamini Y, Hochberg Y, 1995. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B 57, 289–300. [Google Scholar]
- [4].Biswal BB, et al. , 2010. Toward discovery science of human brain function. Proc. Natl. Acad. Sci. U. S. A. 107, 4734–4739. doi: 10.1073/pnas.0911855107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Brieber S, Neufang S, Bruning N, Kamp-Becker I, Remschmidt H, Herpertz-Dahlmann B, Fink GR, Konrad K, 2007. Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J. Child Psychol. Psychiatry 48, 1251–1258. doi: 10.1111/j.1469-7610.2007.01799.x [DOI] [PubMed] [Google Scholar]
- [6].Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL, 2002. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288, 1740–1748. [DOI] [PubMed] [Google Scholar]
- [7].Castellanos FX, Proal E, 2009. Location, location, and thickness: volumetric neuroimaging of attention-deficit/hyperactivity disorder comes of age. J. Am. Acad. Child Adolesc. Psychiatry 48, 979–981. doi: 10.1097/CHI.0b013e3181b45084 [DOI] [PubMed] [Google Scholar]
- [8].Colby JB, Rudie JD, Brown JA, Douglas PK, Cohen MS, Shehzad Z, 2012. Insights into multimodal imaging classification of ADHD. Front. Syst. Neurosci. 6, 59. doi: 10.3389/fnsys.2012.00059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Crow TJ, 1997. Schizophrenia as failure of hemispheric dominance for language. Trends Neurosci. 20, 339–343. [DOI] [PubMed] [Google Scholar]
- [10].Douglas PK, Colby JB, Shehzad Z, Rudie JD, Brown JA, 2012. Multimodal Classification of ADHD: Combining Features Across Domains to Improve Classification. OHBM 374. [Google Scholar]
- [11].Douglas PK, et al. 2018. Hemispheric Brain Asymmetry Differences in Youths with Attention-Deficit/Hyperactivity Disorder. Neuroimage: Clinical Feb 24;18:744–752. doi: 10.1016/j.nicl.2018.02.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Ellison-Wright I, Ellison-Wright Z, Bullmore E, 2008. Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysis. BMC Psychiatry 8, 51. doi: 10.1186/1471-244X-8-51 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Faries DE, Yalcin I, Harder D, Heiligenstein JH, 2001. Validation of the ADHD Rating Scale as a clirlician administered and scored instrument. J. Atten. Disord. 5, 107–115. doi: 10.1177/108705470100500204 [DOI] [Google Scholar]
- [14].Fink GR, Halligan PW, Marshall JC, Frith CD, Frackowiak RS, Dolan RJ, 1996. Where in the brain does visual attention select the forest and the trees? Nature 382, 626–628. doi: 10.1038/382626a0 [DOI] [PubMed] [Google Scholar]
- [15].Fischl B, Dale AM, 2000. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 97, 11050–11055. doi: 10.1073/pnas.200033797 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Gordon H, 2016. Laterality of Brain Activation for Risk Factors of Addiction. Curr. Drug Abuse Rev. 9, 1–18. doi: 10.2174/1874473709666151217121309 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Hale TS, Bookheimer S, McGough JJ, Phillips JM, McCracken JT, 2007. Atypical brain activation during simple & complex levels of processing in adult ADHD: an fMRI study. J. Atten. Disord. 11, 125–140. doi: 10.1177/1087054706294101 [DOI] [PubMed] [Google Scholar]
- [18].Hale TS, Wiley JF, Smalley SL, Tung KL, Kaminsky O, McGough JJ, Jaini AM, Loo SK, 2015. A parietal biomarker for ADHD liability: as predicted by the distributed effects perspective model of ADHD. Front. Psychiatry 6, 63. doi: 10.3389/fpsyt.2015.00063 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Heilman KM, Van Den Abell T, 1980. Right hemisphere dominance for attention: the mechanism underlying hemispheric asymmetries of inattention (neglect). Neurology 30, 327–330. [DOI] [PubMed] [Google Scholar]
- [20].Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E, Jahanshad N, Zeeuw P. de, Szekely E, Sudre G, Wolfers T, Onnink AMH, Dammers JT, Mostert JC, Vives-Gilabert Y, Kohls G, Oberwelland E, Seitz J, Schulte-Rüther M, Ambrosino S, Doyle AE, Høvik MF, Dramsdahl M, Tamm L, van Erp TGM, Dale A, Schork A, Conzelmann A, Zierhut K, Baur R, McCarthy H, Yoncheva YN, Cubillo A, Chantiluke K, Mehta MA, Paloyelis Y, Hohmann S, Baumeister S, Bramati I, Mattos P, Tovar-Moll F, Douglas P, Banaschewski T, Brandeis D, Kuntsi J, Asherson P, Rubia K, Kelly C, Martino AD, Milham MP, Castellanos FX, Frodl T, Zentis M, Lesch K-P, Reif A, Pauli P, Jernigan TL, Haavik J, Plessen KJ, Lundervold AJ, Hugdahl K, Seidman LJ, Biederman J, Rommelse N, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Oosterlaan J, Polier G. von, Konrad K, Vilarroya O, Ramos-Quiroga JA, Soliva JC, Durston S, Buitelaar JK, Faraone SV, Shaw P, Thompson PM, Franke B, 2017. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry. doi: 10.1016/S2215-0366(17)30049-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Hua X, Lee S, Yanovsky I, Leow AD, Chou Y-Y, Ho AJ, Gutman B, Toga AW, Jack CR, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, 2009. Optimizing power to track brain degeneration in Alzheimer’s disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects. NeuroImage 48, 668–681. doi: 10.1016/j.neuroimage.2009.07.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Jiang H, van Zijl PCM, Kim J, Pearlson GD, Mori S, 2006. DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput. Methods Programs Biomed. 81, 106–116. doi: 10.1016/j.cmpb.2005.08.004 [DOI] [PubMed] [Google Scholar]
- [23].Jones DK et al. Isotropic Resolution Diffusion Tensor Imaging With Whole Brain Acquisition in a Clinically Acceptable Time. Human Brain Mapping 15:216–230 (2002) [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Kuperman S, Johnson B, Arndt S, Lindgren S, Wolraich M, 1996. Quantitative EEG differences in a nonclinical sample of children with ADHD and undifferentiated ADD. J. Am. Acad. Child Adolesc. Psychiatry 35, 1009–1017. doi: 10.1097/00004583-199608000-00011 [DOI] [PubMed] [Google Scholar]
- [25].Larisch R, Sitte W, Antke C, Nikolaus S, Franz M, Tress W, Müller H-W, 2006. Striatal dopamine transporter density in drug naive patients with attention-deficit/hyperactivity disorder. Nucl. Med. Commun. 27, 267–270. [DOI] [PubMed] [Google Scholar]
- [26].McCracken JT, 2016. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyeractivity Disorder: A Comparative Study. Journal of the American Academy of Child and Adolescent Psychiatry 55(8), 657–666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].McGough JJ, 2012. Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor. Pharmacogenomics 13, 365–368. doi: 10.2217/pgs.12.5 [DOI] [PubMed] [Google Scholar]
- [28].McGough JJ, McCracken JT, 2000. Assessment of attention deficit hyperactivity disorder: a review of recent literature. Curr. Opin. Pediatr. 12, 319–324. [DOI] [PubMed] [Google Scholar]
- [29].Nakao T, Radua J, Rubia K, Mataix-Cols D, 2011. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am. J. Psychiatry 168, 1154–1163. doi: 10.1176/appi.ajp.2011.11020281 [DOI] [PubMed] [Google Scholar]
- [30].Qiu M, Ye Z, Li Q, Liu G, Xie B, Wang J, 2011. Changes of brain structure and function in ADHD children. Brain Topogr. 24, 243–252. doi: 10.1007/s10548-010-0168-4 [DOI] [PubMed] [Google Scholar]
- [31].Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, Andrew C, Bullmore ET, 2000. Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci. Biobehav. Rev. 24, 13–19. [DOI] [PubMed] [Google Scholar]
- [32].Seidman LJ, Biederman J, Liang L, Valera EM, Monuteaux MC, Brown A, Kaiser J, Spencer T, Faraone SV, Makris N, 2011. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol. Psychiatry 69, 857–866. doi: 10.1016/j.biopsych.2010.09.053 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Shaw P, Lalonde F, Lepage C, Rabin C, Eckstrand K, Sharp W, Greenstein D, Evans A, Giedd JN, Rapoport J, 2009a. Development of cortical asymmetry in typically developing children and its disruption in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 66, 888–896. doi: 10.1001/archgenpsychiatry.2009.103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Shaw P, Sharp WS, Morrison M, Eckstrand K, Greenstein DK, Clasen LS, Evans AC, Rapoport JL, 2009b. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. Am. J. Psychiatry 166, 58–63. doi: 10.1176/appi.ajp.2008.08050781 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [35].Sowell ER, Thompson PM, Welcome SE, Henkenius AL, Toga AW, Peterson BS, 2003. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet Lond. Engl. 362, 1699–1707. doi: 10.1016/S0140-6736(03)14842-8 [DOI] [PubMed] [Google Scholar]
- [36].Stefanatos GA, Wasserstein J, 2001. Attention deficit/hyperactivity disorder as a right hemisphere syndrome. Selective literature review and detailed neuropsychological case studies. Ann. N. Y. Acad. Sci. 931, 172–195. [PubMed] [Google Scholar]
- [37].Steinmetz H, Fürst G, Freund HJ, 1990. Variation of perisylvian and calcarine anatomic landmarks within stereotaxic proportional coordinates. AJNR Am. J. Neuroradiol. 11, 1123–1130. [PMC free article] [PubMed] [Google Scholar]
- [38].Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S, 1998. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol. Psychiatry 3, 38–41. [DOI] [PubMed] [Google Scholar]
- [39].Thiebaut de Schotten M, Dell’Acqua F, Forkel SJ, Simmons A, Vergani F, Murphy DGM, Catani M, 2011. A lateralized brain network for visuospatial attention. Nat. Neurosci. 14, 1245–1246. doi: 10.1038/nn.2905 [DOI] [PubMed] [Google Scholar]
- [40].Thompson PM, Hayashi KM, De Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW, 2004. Mapping hippocampal and ventricular change in Alzheimer disease. NeuroImage 22, 1754–1766. doi: 10.1016/j.neuroimage.2004.03.040 [DOI] [PubMed] [Google Scholar]
- [41].Thompson PM, Moussai J, Zohoori S, Goldkorn A, Khan AA, Mega MS, Small GW, Cummings JL, Toga AW, 1998. Cortical variability and asymmetry in normal aging and Alzheimer’s disease. Cereb. Cortex N. Y. N 1991 8, 492–509. [DOI] [PubMed] [Google Scholar]
- [42].Toga AW, Thompson PM, 2003. Mapping brain asymmetry. Nat. Rev. Neurosci. 4, 37–48. doi: 10.1038/nrn1009 [DOI] [PubMed] [Google Scholar]
- [43].van Ewijk H, Heslenfeld DJ, Zwiers MP, Buitelaar JK, Oosterlaan J, 2012. Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 36, 1093–1106. doi: 10.1016/j.neubiorev.2012.01.003 [DOI] [PubMed] [Google Scholar]
- [44].Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, Perou R, Blumberg SJ, 2014. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. J. Am. Acad. Child Adolesc. Psychiatry 53, 34–46.e2. doi: 10.1016/j.jaac.2013.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [45].Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J, 1996. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J. Am. Acad. Child Adolesc. Psychiatry 35, 319–324. doi: 10.1097/00004583-199603000-00013 [DOI] [PubMed] [Google Scholar]
- [46].Woo BSC, Rey JM, 2005. The Validity of the DSM-IV Subtypes of Attention-Deficit/Hyperactivity Disorder. Aust. N. Z. J. Psychiatry 39, 344–353. doi: 10.1080/j.1440-1614.2005.01580.x [DOI] [PubMed] [Google Scholar]
- [47].Yamaguchi S, Yamagata S, Kobayashi S, 2000. Cerebral asymmetry of the “top-down” allocation of attention to global and local features. J. Neurosci. Off. J. Soc. Neurosci. 20, RC72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [48].Yan C, Gong G, Wang J, Wang D, Liu D, Zhu C, Chen ZJ, Evans A, Zang Y, He Y, 2011. Sex- and Brain Size-Related Small-World Structural Cortical Networks in Young Adults: A DTI Tractography Study. Cereb. Cortex 21, 449–458. doi: 10.1093/cercor/bhq111 [DOI] [PubMed] [Google Scholar]
- [49].Yordanova J, Kolev V, Rothenberger A, 2013. Event-related oscillations reflect functional asymmetry in children with attention deficit/hyperactivity disorder. Suppl. Clin. Neurophysiol. 62, 289–301. [DOI] [PubMed] [Google Scholar]
- [50].Zhang S, Faries DE, Vowles M, Michelson D, 2005. ADHD rating scale IV: psychometric properties from a multinational study as clinician-administered instrument. Int. J. Methods Psychiatr. Res. 14, 186–201. doi: 10.1002/mpr.7 [DOI] [PMC free article] [PubMed] [Google Scholar]
